AlloVir Stock (NASDAQ: ALVR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 893.387K |
Day Range | - - - |
52 Wk Range | 0.623 - 6.120 |
Market Cap | $86.152M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 9.7% |
Days to Cover | 11.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AlloVir (NASDAQ: ALVR) through any online brokerage.
Other companies in AlloVir’s space includes: Anixa Biosciences (NASDAQ:ANIX), Connect Biopharma Hldgs (NASDAQ:CNTB), Curis (NASDAQ:CRIS), Burning Rock Biotech (NASDAQ:BNR) and Armata Pharmaceuticals (AMEX:ARMP).
The latest price target for AlloVir (NASDAQ: ALVR) was reported by B of A Securities on Tuesday, December 26, 2023. The analyst firm set a price target for 1.00 expecting ALVR to rise to within 12 months (a possible 33.33% upside). 7 analyst firms have reported ratings in the last year.
The stock price for AlloVir (NASDAQ: ALVR) is $0.75 last updated April 18, 2024 at 7:56 PM EDT.
There are no upcoming dividends for AlloVir.
AlloVir’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for AlloVir.
AlloVir is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.